【摘 要】
：
Ten years ago,in 2011,we founded Acta Pharmaceutica Sinica B(APSB) with the goal of creating a global high-level forum centered around drug discovery and pharmaceutical research/application.Our first priority was and will always be to serve our readers an
论文部分内容阅读
Ten years ago,in 2011,we founded Acta Pharmaceutica Sinica B(APSB) with the goal of creating a global high-level forum centered around drug discovery and pharmaceutical research/application.Our first priority was and will always be to serve our readers and the best way is to diligently curate our publications to ensure the high quality of our articles.For our efforts,APSB was included by the Chemical Abstract in 2011,accepted by PubMed Central in 2015,indexed by Science Citation Index in 2017 and has evolved to become one of the most important international journals in the field of pharmaceutical sciences.
其他文献
目的:建立采用核磁共振氢谱(1H NMR)对伐地那非进行定性和定量分析的方法.方法:将样品与经氢氧化钠碱化后的美国药典委员会(USP)对照品进行1H NMR比对鉴别;采用Bruker AVANCE NEOAscend 600型核磁共振波谱仪,脉冲序列zg90,恒温25℃,驰豫延迟时间(D1)30 s.以1,3,5-三甲氧基苯为内标物,氘代二甲基亚砜(DMSO-d6)为溶剂,采用定量核磁共振氢谱法(qHNMR法)测定伐地那非的含量,同时含量测定结果与质量平衡法和外标法测定结果进行比较.结果:伐地那非样品的1
目的:采用酸辅助微波消解技术,建立测定减肥类保健食品中总左旋肉碱的液相色谱-串联质谱/质谱方法(HPLC-MS/MS).方法:样品加水超声溶解后,再经酸辅助微波消解(120℃,40 min)处理;消解溶液经稀释后,采用Agilent Zorbax 300-SCX(3.0mm×50 mm,1.8 μm)色谱柱进行分离,以5 mmol·L-1甲酸铵乙腈-水(1∶1,含0.2％甲酸)为流动相A,30 mmol·L-1甲酸铵乙腈-水(1∶1,含0.2％甲酸)为流动相B,进行梯度洗脱.在质谱电喷雾(ESI)正离子模
目的:建立一种用拉曼光谱技术快速测定石膏中二水硫酸钙含量的方法.方法:首先以硝酸钠作为内标,氯化钠作为填充剂,与石膏样品混合研磨均匀,在室温干燥条件下,压片,然后进行拉曼光谱测定.测定条件:激发波长780 nm,激光功率24 mW,光阑50 μm slit,10倍物镜,曝光时间2 s,累积2次,扫描范围300～1 700 cm-1.结果:二水硫酸钙质量分数在5％～35％范围内与二水硫酸钙和硝酸钠的拉曼特征峰强度比值(I1 007/I1 068)呈良好的线性关系,线性回归方程为Y=0.019X-0.035
The use of lipid nanocarriers for drug delivery applications is an active research area,and a great interest has particularly been shown in the past two decades.Among different lipid nanocarriers,ISAsomes(Internally self-assembled somes or particles),incl
Monomethoxy poly(ethylene glycol)-block-poly(D,L-lactic acid)(PEG-PLA)is a typical amphiphilic di-block copolymer widely used as a nanoparticle carrier(nanocarrier)in drug delivery.Un-derstanding the in vivo fate of PEG-PLA is required to evaluate its ove
Since the commercialization of the first liposomes used for drug delivery,Doxil/Caelyx? and Myocet?,tremendous progress has been made in understanding interactions between nanomedicines and biological systems.Fundamental work at the interface of engineeri
The initiation and development of major inflammatory diseases,i.e.,cancer,vascular inflam-mation,and some autoimmune diseases are closely linked to the immune system.Biologics-based immu-notherapy is exerting a critical role against these diseases,whereas
Heart failure(HF)is a global public health problem with high morbidity and mortality.A large number of studies have shown that HF is caused by severe energy metabolism disorders,which result in an insufficient heart energy supply.This deficiency causes ca
When nanoparticles were introduced into the biological media,the protein corona would be formed,which endowed the nanoparticles with new bio-identities.Thus,controlling protein corona for-mation is critical to in vivo therapeutic effect.Controlling the pa
As one of the most important components of caveolae,caveolin-1 is involved in caveolae-mediated endocytosis and transcytosis pathways,and also plays a role in regulating the cell membrane cholesterol homeostasis and mediating signal transduction.In recent